CME Group Inc. (NASDAQ:CME) Holdings Lowered by US Bancorp DE

US Bancorp DE trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 375,566 shares of the financial services provider’s stock after selling 12,685 shares during the period. US Bancorp DE owned approximately 0.10% of CME Group worth $82,869,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. HM Payson & Co. raised its position in CME Group by 33.6% during the third quarter. HM Payson & Co. now owns 962 shares of the financial services provider’s stock valued at $212,000 after buying an additional 242 shares during the period. Goldstone Financial Group LLC acquired a new position in CME Group during the third quarter valued at $1,265,000. Solidarity Wealth LLC raised its position in CME Group by 48.8% during the third quarter. Solidarity Wealth LLC now owns 18,610 shares of the financial services provider’s stock valued at $4,106,000 after buying an additional 6,100 shares during the period. Oak Harvest Investment Services raised its position in CME Group by 5.2% during the third quarter. Oak Harvest Investment Services now owns 53,775 shares of the financial services provider’s stock valued at $11,865,000 after buying an additional 2,639 shares during the period. Finally, Pinnacle Associates Ltd. raised its position in CME Group by 88.4% during the third quarter. Pinnacle Associates Ltd. now owns 6,907 shares of the financial services provider’s stock valued at $1,455,000 after buying an additional 3,241 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of NASDAQ CME opened at $225.36 on Friday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $81.15 billion, a price-to-earnings ratio of 23.70, a P/E/G ratio of 7.76 and a beta of 0.55. The business’s 50-day simple moving average is $220.36 and its 200-day simple moving average is $209.34. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.25 EPS. As a group, equities research analysts expect that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.04%. CME Group’s payout ratio is 48.37%.

Insider Activity at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,221 shares of company stock worth $3,351,895 in the last 90 days. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target on the stock. in a research report on Tuesday, October 8th. JPMorgan Chase & Co. upped their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Bank of America upped their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Finally, Oppenheimer upped their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.